PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Jan-2024 ZetrOZ Systems to Demonstrate sam Wearable Ultrasound Unit at Las Vegas Conference AccessWire
24-Jan-2024 Ainos Announces $1.75 Million Follow-On Funding AccessWire
24-Jan-2024 Neptune Retains Stifel to Explore Strategic Alternatives for Sprout Organics AccessWire
24-Jan-2024 SingleTimeMicroneedles, Inc. Selected as Finalist for 2024 SXSW Pitch AccessWire
24-Jan-2024 Emergency Care Partners Establishes a New Partner Group in Missouri AccessWire
24-Jan-2024 Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets EVAXION
24-Jan-2024 Otsuka announces topline results from Ionis’ Phase 3 OASIS-HAE study of investigational donidalorsen in patients with hereditary angioedema Otsuka Pharmaceutical Europe Ltd
24-Jan-2024 LEO Pharma announces positive phase 3 head-to-head data results from DELTA FORCE trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (CHE) LEO Pharma
24-Jan-2024 LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals LEO Pharma
24-Jan-2024 Lexaria Releases Annual Letter from the CEO AccessWire
24-Jan-2024 Monogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024 AccessWire
24-Jan-2024 Modular Medical Announces Issuance of New US Patent AccessWire
24-Jan-2024 Pima Heart & Vascular Hosts Leading Cardiology Conference in Tucson This February AccessWire
24-Jan-2024 PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its’ Nutraceutical Formulations AccessWire
24-Jan-2024 Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd Olympus
24-Jan-2024 Unlocking Product Validation: Bioz and CE Elantech Set a New Standard for Success in Scientific Research Newswire
24-Jan-2024 Unlocking Product Validation: Bioz and CE Elantech Set a New Standard for Success in Scientific Research AccessWire
24-Jan-2024 Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 ABIVAX
23-Jan-2024 Planet 13 Provides Further Update Regarding Access to Certain Cash Accounts AccessWire
23-Jan-2024 NHI Announces Fourth Quarter 2023 Earnings Release and Conference Call Date AccessWire